VEGFA and coronary artery disorder: The results showed that levels of VEGF in the GCF of all groups with the disease were significantly higher compared to the control group (with a significance level of (p ≤ 0.05), suggesting that VEGF can be considered a biomarker in the progression of coronary heart disease [24].